Innovations in organ donation

Mount Sinai Journal of Medicine

Volumn 79, Issue 3, 2012, Pages 351-364

  Goldstein, Michael J ^a,b   Lubezky, Nir ^a   Yushkov, Yuriy ^b   Bae, Coney ^c   Guarrera, James V ^c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b New York Organ Donor Network   (United States)

^c Department of Medicine   (United States)

Author keywords

Donation; Organ; Preservation

Indexed keywords

BRAIN DEATH; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HUMAN; ORGAN DONOR; ORGAN PERFUSION; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; RESUSCITATION; REVIEW; UNITED STATES;

BRAIN DEATH; DIFFUSION OF INNOVATION; HUMANS; ORGAN TRANSPLANTATION; PERFUSION; TISSUE AND ORGAN PROCUREMENT;

EID: 84862170494     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.21312     Document Type: Review

References (114)

1. 2009 OPTN/SRTR Annual Report, Transplant Data 1999-2008. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2009.
2. Leichtman AB, Cohen D, Keith D, et al. Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant 2008; 8(4 part 2): 946-957. (Pubitemid 351389063)
3. National Conference of Commissioners on Uniform State Laws. Revised Uniform Anatomical Gift Act. http://www.law.upenn.edu/bll/archives/ulc/uaga/ 2009final.pdf. Published 2006. Revised 2009. Accessed October 31, 2011.
4. Beloucif S. Opt-in or opt-out for organ transplantation. Curr Opin Anaesthesiol 2012; 25: 199-203.
5. Donate Life America. National Donor Designation Report Card. http://donatelife.net/wp-content/uploads/2011/04/DLA-Report-BKLT-30733-2.pdf. Published April 2011. Accessed October 31, 2011.
6. Rosenblum AM, Horvat LD, Siminoff LA, et al. The authority of next-of-kin in explicit and presumed consent systems for deceased organ donation: an analysis of 54 nations. Nephrol Dial Transplant 2011; doi:10.1093/ndt/gfr619.
7. Shafer TJ, Wagner D, Chessare J, et al. US organ donation breakthrough collaborative increases organ donation. Crit Care Nurs Q 2008; 31: 190-210.
8. US Department of Health and Human Services, Health Resources and Services Administration. Donation and Transplantation Community of Practice. http://www.hrsa.gov/communitiesofpractice/AtaGlance/organdonation.pdf. Accessed October 31, 2011.
9. United Network for Organ Sharing. Organ allocation. http://www.unos.org/ donation/index.php?topic=organ-allocation. Published 2012. Accessed October 31, 2011.
10. Watts G. Joseph Murray: innovative surgeon and pioneer of transplantation. Lancet 2011; 377: 987.
11. Weitz J, Koch M, Mehrabi A, et al. Living-donor kidney transplantation: risks of the donor-benefits of the recipient. Clin Transplant 2006; 20(suppl 17):13-16. (Pubitemid 44697896)
12. Sutherland DE, Radosevich D, Gruessner R, et al. Pushing the envelope: living donor pancreas transplantation. Curr Opin Organ Transplant 2012;17: 106-115.
13. Chen F, Fujinaga T, Shoji T, et al. Outcomes and pulmonary function in living lobar lung transplant donors. Transpl Int 2012; 25: 153-157.
14. Tzvetanov IG, Oberholzer J, Benedetti E. Current status of living donor small bowel transplantation. Curr Opin Organ Transplant 2010; 15: 346-348.
15. Jeon H, Lee SG. Living donor liver transplantation. Curr Opin Organ Transplant 2010; 15: 283-287.
16. Yeh H, Olthoff KM. Live donor adult liver transplantation. Curr Opin Organ Transplant 2008; 13: 241-246.
17. Ratner LE, Montgomery RA, Kavoussi LR. Laparoscopic live donor nephrectomy: a review of the first 5 years. Urol Clin North Am 2001; 28: 709-719. (Pubitemid 34028035)
18. Fabrizio MD, Ratner LE, Kavoussi LR. Laparoscopic live donor nephrectomy: pro. Urology 1999; 53: 665-667. (Pubitemid 29163026)
19. Choi KH, Yang SC, Lee SR, et al. Standardized videoassisted retroperitoneal minilaparotomy surgery for 615 living donor nephrectomies. Transpl Int 2011; 24: 973-983.
20. Shirodkar SP, Gorin MA, Sageshima J, et al. Technical modification for laparoscopic donor nephrectomyto minimize testicular pain: a complication with significant morbidity. Am J Transplant 2011; 11: 1031-1034.
21. Wadström J, Biglarnia A, Gjertsen H, et al. Introducing hand-assisted retroperitoneoscopic live donor nephrectomy: learning curves and development based on 413 consecutive cases in four centers. Transplantation 2011; 91: 462-469.
22. Pietrabissa A, Abelli M, Spinillo A, et al. Roboticassisted laparoscopic donor nephrectomy with transvaginal extraction of the kidney. AmJ Transplant 2010; 10: 2708-2711.
23. Kohei N, Kazuya O, Hirai T, et al. Retroperitoneoscopic living donor nephrectomy: experience of 425 cases at a single center. J Endourol 2010; 24: 1783-1787.
24. Segev DL, Gentry SE, Warren DS, et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883-1890. (Pubitemid 40548185)
25. Blumberg JM, Gritsch H, Veale JL. Kidney paired donation: advancements and future directions. Curr Opin Organ Transplant 2011; 16: 380-384.
26. Duke PK, Ramsay MA, Gunning TC, et al. Perioperative hemodynamic heterogeneity of brain dead organ donors. Transpl Int 1992; 5(suppl 1):S719-S721.
27. Mascia L, Mastromauro I, Viberti S, et al. Management to optimize organ procurement in brain dead donors. Minerva Anestesiol 2009; 75: 125-133.
28. Power BM, Van Heerden PV. The physiological changes associated with brain death-current concepts and implications for treatment of the brain dead organ donor. Anaesth Intensive Care 1995; 23: 26-36.
29. Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year review from a level I trauma center. J Trauma 1990; 30: 728-732. (Pubitemid 20197989)
30. Grossman MD, Reilly PM, McMahon D, et al. Who pays for failed organ procurement and what is the cost of altruism? Transplantation 1996; 62: 1828-1831. (Pubitemid 27014547)
31. Powner DJ, Boccalandro C, Alp MS, et al. Endocrine failure after traumatic brain injury in adults. Neurocrit Care 2006; 5: 61-70. (Pubitemid 44379156)
32. Schneider M, Schneider HJ, Stalla GK. Anterior pituitary hormone abnormalities following traumatic brain injury. J Neurotrauma 2005; 22: 937-946. (Pubitemid 41362060)
33. Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351: 2730-2739. (Pubitemid 39665326)
34. United Network for Organ Sharing. Critical Pathway for the Organ Donor. http://www.unos.org/docs/Critical-Pathway.pdf. Accessed October 31, 2011.
35. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: 836-841.
36. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010; 304: 2620-2627.
37. Hadjizacharia P, Salim A, Brown C, et al. Does the use of pulmonary artery catheters increase the number of organs available for transplantation? Clin Transplant 2010: 62-66.
38. Malinoski DJ, Daly MC, Patel MS, et al. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma 2011; 71: 990-996.
39. Franklin GA, Santos AP, Smith JW, et al. Optimization of donor management goals yields increased organ use. Am Surg 2010; 76: 587-594.
40. De Vries DK, Lindeman JH, Ringers J, et al. Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. Am J Transplant 2011; 11: 1064-1070.
41. Hoeger S, Bergstraesser C, Selhorst J, et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant 2010; 10: 477-489.
42. Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 2009; 53: 425-435.
43. Kuecuek O, Mantouvalou L, Klemz R, et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc 2005; 37: 387-388. (Pubitemid 40459796)
44. Lustbader D, O'Hara D, Wijdicks EF, et al. Second brain death examination may negatively affect organ donation. Neurology 2011; 76: 119-124.
45. Wijdicks EF, Varelas PN, Gronseth GS, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010; 74: 1911-1918.
46. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995; 46: 235-247.
47. Taylor MJ, Baicu SC. Current state of hypothermic machine perfusion preservation of organs: the clinical perspective. Cryobiology 2010; 60(3 suppl):S20-S35.
48. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83: 1289-1298. (Pubitemid 46800302)
49. Lynch RJ, Kubus J, Chenault RH, et al. Comparison of histidine- tripthophane-ketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008; 2008: 567-573.
50. Global Industry Analysts, Inc. Global Organ Preservation Solutions Market to Reach US$48.8 Million by 2015. http://www.strategyr.com/Organ- Preservation-Solutions-Market-Report.asp. Published October 10, 2011. Accessed October 31, 2011.
51. Feng L, Zhao N, Yao X, et al. Histidine-tryptophanketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl 2007; 13: 1125-1136. (Pubitemid 47305031)
52. De Boer J, De Meester J, Smits JM, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transplant Int 1999; 12: 447-453. (Pubitemid 30009069)
53. Agarwal A, Murdock P, Fridell JA. Comparison of histidine-trypthophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006; 81: 480-482. (Pubitemid 43255739)
54. Eghtesad B, Aucejo F, Fung JJ. Preservation solutions in liver transplantation: what are the options? Liver Transpl 2006; 12: 196-198. (Pubitemid 43273775)
55. Roels L, Coosemans W, Donck J, et al. Inferior outcome of cadaveric kidneys preserved for morethan 24 hr in histidine-tryptophan-ketoglutarate solution. Transplantation 1998; 66: 1660-1664. (Pubitemid 29034987)
56. Alonso D, Dunn TB, Rigley T, et al. Increased pancreatitis in allografts flushed with histidinetryptophan-ketoglutarate solution: a cautionary tale. Am J Transplant 2008; 8: 1942-1945.
57. Stevens RB, Skorupa JY, Rigley TH, et al. Increased primary non-function in transplanted deceaseddonor kidneys flushed with histidine- tryptophanketoglutarate solution. Am J Transplant 2009; 9: 1055-1062.
58. Opelz G, Döhler B. Multicenter analysis of kidney preservation. Transplantation 2007; 83: 247-253.
59. Stewart ZA, Cameron AM, Singer AL, et al. Histidinetryptophan- ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009; 9: 217-221.
60. Stewart ZA, Lonze BE, Warren DS, et al. Histidinetryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants. Am J Transplant 2009; 9: 1048-1054.
61. Stewart ZA, Cameron AM, Singer AL, et al. Histidinetryptophan- ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009; 9: 286-293.
62. Oto T, Griffiths AP, Rosenfeldt F, et al. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 2006; 82: 1842-1848. (Pubitemid 44584905)
63. Marasco SF, Bailey M, McGlade D, et al. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant. 2011; 30: 414-419.
64. Dondéro F, Paugam-Burtz C, Danjou F, et al. A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation. Ann Transplant 2010; 15: 7-14.
65. Schreinemachers MC, Doorschodt BM, Florquin S, et al. Improved preservation and microcirculation with Polysol after transplantation in a porcine kidney autotransplantation model. Nephrol Dial Transplant 2009; 24: 816-824.
66. Yu LF, Qiu BY, Nan FJ, et al. AMPK activators as novel therapeutics for type 2 diabetes. Curr Top Med Chem 2010; 10: 397-410.
67. Guh JH, Chang WL, Yang J, et al. Development of novel adenosine monophosphate-activated protein kinase activators. J Med Chem 2010; 53: 2552-2561.
68. Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010; 1804: 581-591.
69. Kim T, Davis J, Zhang AJ, et al. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009; 388: 377-382.
70. Gruzman A, Babai G, Sasson S. Adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations. Rev Diabet Stud 2009; 6: 13-36.
71. Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007; 47: 185-210.
72. Kim YI, Hwang YJ, Song KE, et al. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. J Am Coll Surg 2002; 195: 41-50.
73. Kotsch K, Ulrich F, Reutzel-Selek A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial [published correction appears in Ann Surg 2011;254:391]. Ann Surg 2008; 248: 1042-1050.
74. Bogetti D, Sankary HN, Jarzembowski TM, et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant 2005; 19: 507-511. (Pubitemid 40990661)
75. McLarren AJ, Friend PJ. Trends in organ preservation. Transpl Int 2003:16: 701-708. (Pubitemid 37408589)
76. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673-676.
77. Polyak MM, Arrington BO, Stubenbord WT, et al. The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation 2000; 69: 249-258. (Pubitemid 30075283)
78. Guarrera JV, Estevez J, Boykin J, et al. Hypothermic machine perfusion of liver grafts for transplantation: technical development in human discard and miniature swine models. Transplant Proc 2005; 37: 323-325. (Pubitemid 40459773)
79. Moers C, Smits JM, Maathuis MJ, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7-19.
80. Doorschodt BM, Schreinemachers MC, Florquin S, et al. Evaluation of a novel system for hypothermic oxygenated pulsatile perfusion preservation. Int J Artif Organs 2009; 32: 728-738.
81. Doorschodt BM, Schreinemachers MC, Behbahani M, et al. Hypothermic machine perfusion of kidney grafts: which pressure is preferred? Ann Biomed Eng 2011; 39: 1051-1059.
82. Guarrera JV, Karim NA. Liver preservation: is there anything new yet? Curr Opin Organ Transplant 2008; 13: 148-154. (Pubitemid 351374252)
83. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010; 10: 372-381.
84. Guarrera JV, Henry SD, Chen SW, et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res 2011; 167: e365-e373.
85. Lee CY, Zhang JX, Jones JW Jr, et al. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation 2002; 74: 944-951. (Pubitemid 35191241)
86. Bessems M, Doorschodt BM, van Vliet AK, et al. Machine perfusion preservation of the non-heartbeating donor rat livers using polysol, a new preservation solution. Transplant Proc 2005; 37: 326-328. (Pubitemid 40459774)
87. Iwamoto H, Matsuno N, Narumi Y, et al. Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. Transplant Proc 2000; 32: 1645-1646.
88. Kaufman BJ, Wall SP, Gilbert AJ, et al; New York City Uncontrolled Donation after Cardiac DeathStudy Group. Success of organ donation after out-of-hospital cardiac death and the barriers to its acceptance. Crit Care 2009; 13: 189.
89. Magliocca JF, Magee JC, Rowe SA, et al. Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma 2005; 58: 1095-1102. (Pubitemid 41020090)
90. Farney AC, Singh RP, Hines MH, et al. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg 2008; 206: 1028-1037.
91. Valero R, Cabrer C, Oppenheimer F, et al. Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors. Transpl Int 2000; 13: 303-310.
92. Fondevila C, Hessheimer AJ, Ruiz A, et al. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant 2007; 7: 1849-1855. (Pubitemid 46905436)
93. Bernat JL. The boundaries of organ donation after circulatory death. N Engl J Med 2008; 359: 669-671.
94. Bernat JL. How autoresuscitation impacts death determination in organ donors. Crit Care Med 2010; 38: 1377-1378.
95. Englesbe MJ, Woodrum D, Debroy M, et al. Salvage of an unstable brain dead donor with prompt extracorporeal support. Transplantation 2004; 78: 1815. (Pubitemid 40041651)
96. Ke HY, Lin CY, Tsai YT, et al. Increase the donor pool: transportation of a patient with fatal head injury supported with extracorporeal membrane oxygenation. J Trauma 2010; 68: E87-E88.
97. Zuckerman JM, Singh RP, Farney AC, et al. Successful kidney transplantation from a donation after cardiac death donor with acute renal failure and bowel infarction using extracorporeal support. Transpl Int 2009; 22: 798-804.
98. Brasile L, Stubenitsky BM, Booster MH, et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002; 73: 897-901. (Pubitemid 34252351)
99. Imber CJ, St Peter SD, Lopez de Cenarruzabeitia, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002; 73: 701-709. (Pubitemid 34260564)
100. Cypel M, Yeung JC, Hirayam S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27: 1319-1325.
101. Cypel M, Yeung JC, Mingyao L, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431-1440.
102. Wierup P, Haraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 2006; 81: 460-466. (Pubitemid 43120535)
103. Sakuma T, Gu X, Wang Z, et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit Care Med 2006; 34: 676-681.
104. Inci I, Zhai W, Artni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from nonheart beating donors. J Heart Lung Transplant 2007; 26: 1054-1060. (Pubitemid 47494662)
105. Inci I, Ampollini L, Arni S, et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008; 27: 1229-1236.
106. Karamanou DM, Perry J, Walden HR, et al. The effect of ex-vivo perfusion on the microbial profile of the donor lung. J Heart Lung Transplant 2010; 29(suppl 2):S94.
107. Cypel M, Rubach M, Yeung JC, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9: 2262-2269.
108. Hosgood SA, Barlow AD, Yates PJ, et al. A pilot study assessing the feasibility of a short period of normothermic preservation in an experimental model of non heart beating donor kidneys. J Surg Res 2011; 171: 283-290.
109. Kay MD, Hosgood SA, Harper SJ, et al. Normothermic versus hypothermic ex vivo flush using a novel phosphate-free preservation solution (AQIX) in porcine kidneys. J Surg Res 2011; 171: 275-282.
110. Hosgood SA, Nicholson ML. First in man renal transplantation after ex vivo normothermic perfusion. Transplantation 2011; 92: 735-738.
111. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart & Lung Transplantation: Twenty-Sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 2009; 28: 1007-1022.
112. Rosenbaum DH, Peltz M, DiMaio JM, et al. Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. J Heart Lung Transplant 2008; 27: 93-99.
113. Ozeki T, Kwon MH, Gu J, et al. Heart preservation using continuous ex vivo perfusion improves viability and functional recovery. Circ J 2007; 71: 153-159. (Pubitemid 46045565)
114. Garbade J, Krautz C, Aupperle H. Functional, metabolic, and morphological aspects of continuous, normothermic heart preservation: effects of different preparation and perfusion techniques. Tissue Eng Part C Methods 2009; 15: 275-283.